A Hypothesis: Can Erythropoietin Administration Affect the Severity of Retinopathy in Diabetic Patients With Renal Failure?
- 1 October 2007
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 334 (4) , 260-264
- https://doi.org/10.1097/maj.0b013e3180a5e8ed
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?Nephrology, 2006
- Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic RetinopathyNew England Journal of Medicine, 2005
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology, 2003
- Treatment of anemia in the diabetic patient with retinopathy and kidney diseaseAmerican Journal of Ophthalmology, 2003
- Effects of haemodialysis on diabetic macular leakageBritish Journal of Ophthalmology, 2000
- Erythropoietin and Visual Hallucinations in Patients on DialysisPsychosomatics, 1998
- The relationship between hemoglobin levels and diabetic retinopathyJournal of Clinical Epidemiology, 1997
- Erythropoietin in diabetic macular edema and renal insufficiencyAmerican Journal of Kidney Diseases, 1995
- Long-term follow-up study of 268 diabetic patients undergoing haemodialysis, with special attention to visual acuity and heterogeneityNephrology Dialysis Transplantation, 1993
- The visual status of diabetics on renal replacement therapy (RRT)Eye, 1987